Cell Death and DiseaseCell BiologyPeer-reviewed journal article
Heme drives cardiac endothelial senescence in sepsis via STING activation
Tingting LiiD, Peilin ZhuiD, Jialing WangiD, Tao ZhangiD, Joseph AdamsiD, Fei TuiD, Chloe G. GarbeiD, Xiaojin Zhang, Li LiuiD, Krishna SinghiD, David L. WilliamsiD, Chuanfu LiiD, Xiaohui WangiD
Abstract
Sepsis-induced cardiac dysfunction is a major contributor to sepsis-related mortality, and many patients continue to experience long-term cardiac complications after recovery. Here, we demonstrate that cardiac senescence is a key feature of sepsis-associated cardiac dysfunction, with endothelial cells identified as the predominant senescent population in septic cardiac tissue. Yet, the pathogenic drivers of endothelial senescence in sepsis remain poorly characterized. Among potential mediators, we found that elevated levels of heme, a byproduct of hemolysis, strongly correlate with increased endothelial senescence and impaired cardiac function. Mechanistic studies revealed that heme acts as a novel ligand for STING, exacerbating bacterial infection induced STING polymerization and activation, thereby promoting endothelial senescence. Notably, either STING inhibition or enhanced heme clearance via increased hemopexin expression significantly alleviated cardiac endothelial senescence and facilitated cardiac functional recovery in septic mice. These findings identify heme as a critical pathogenic driver of endothelial senescence and highlight heme clearance as a promising therapeutic strategy for mitigating sepsis induced cardiac dysfunction.
- organism: mouse
- research focus: host-pathogen & immune response
- research focus: cell type annotation
- research focus: differential expression
- approach: experimental assay
- Citations
- 6
- FWCI
- 4.16
- Field percentile
- top 5%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Mitochondrial-targeted therapy with elamipretide preserves cardiac function and prevents late mortality in murine sepsis-induced cardiac dysfunction.
Jennie Vu, Cory S. Wagg, … Stephane L. Bourque·bioRxiv·Jul 9, 2026
- Mitochondrial Electron Transport Chain Disruption and Oxidative Stress in Lipopolysaccharide-Induced Cardiac Dysfunction in rats and mice
Agda Aline Pereira de Sousa, Leonardo da Silva Chaves, Heberty Tarso Facundo·Free Radical ResearchPeer-reviewed·May 4, 2025
- Clearance of senescent cells during cardiac ischemia-reperfusion injury improves heart recovery following myocardial infarction
E. Dookun, A. Walaszczyk, … G. D. Richardson·bioRxiv·Apr 28, 2020
- Hepatic IRE1 Protects Against Septic Cardiac Failure
M. Li, R. R. Berton, … L. Yang·bioRxiv·Mar 14, 2023
- Advanced Age in Mice Exacerbates Sepsis-Induced Inflammation, Vascular Permeability, and Multi-Organ Dysfunction
Han Noo Ri Lee, Jason Lin, … Brandon Baer·ShockPeer-reviewed·Jun 26, 2025
- Senescence and DNA Damage-Induced Inflammation Drive Heart Failure with Preserved Ejection Fraction in Cardiovascular Kidney Metabolic Syndrome
Dao‐Fu Dai, Jun‐yi Zhu, … Zhe Han·bioRxiv·Apr 16, 2026